We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$7.44B
AUM Growth
+$696M
Cap. Flow
+$295M
Cap. Flow %
3.96%
Top 10 Hldgs %
25.63%
Holding
169
New
15
Increased
63
Reduced
24
Closed
17

Top Buys

Rank Stock Value
1
ZYME icon
Zymeworks
ZYME
+$57.2M
2
NCNO icon
nCino
NCNO
+$41.7M
3
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$35.5M
4
ARGX icon
argenx
ARGX
+$33.8M
5
SHLS icon
Shoals Technologies Group
SHLS
+$31.8M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$52M
2
VRSK icon
Verisk Analytics
VRSK
+$37.6M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$26.1M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$24.1M
5
OKTA icon
Okta
OKTA
+$23.8M

Sector Composition

Rank Sector Weight
1 Healthcare 35.75%
2 Technology 29.25%
3 Industrials 12.31%
4 Consumer Discretionary 7.52%
5 Communication Services 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRWD icon
1
CrowdStrike
CRWD
$189B
$224M 3.01%
3,565,140
– –
ASND icon
2
Ascendis Pharma A/S
ASND
$16.5B
$223M 3%
1,698,648
– –
FIVN icon
3
FIVE9
FIVN
$2.12B
$216M 2.91%
1,180,515
+1,773
+0.2% +$306K
EXAS
4
DELISTED
Exact Sciences
EXAS
$216M 2.91%
1,740,000
– –
TTD icon
5
Trade Desk
TTD
$8.59B
$213M 2.86%
2,756,430
+13,180
+0.5% +$842K
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$193M 2.6%
1,990,797
-24,203
-1% -$1.96M
DT icon
7
Dynatrace
DT
$12.8B
$160M 2.14%
2,730,308
+52,500
+2% +$2.74M
MTD icon
8
Mettler-Toledo International
MTD
$27.9B
$155M 2.08%
112,000
+9,000
+9% +$11.6M
TWLO icon
9
Twilio
TWLO
$29B
$155M 2.08%
393,490
+1,400
+0.4% +$486K
IDXX icon
10
Idexx Laboratories
IDXX
$44.1B
$152M 2.04%
240,000
– –
ROP icon
11
Roper Technologies
ROP
$38.5B
$147M 1.97%
312,400
+1,700
+0.5% +$752K
HUBS icon
12
HubSpot
HUBS
$11.9B
$139M 1.86%
237,937
+950
+0.4% +$495K
LRCX icon
13
Lam Research
LRCX
$372B
$133M 1.79%
2,044,460
– –
GNRC icon
14
Generac Holdings
GNRC
$11.3B
$131M 1.76%
315,800
+86,600
+38% +$29.1M
FVRR icon
15
Fiverr
FVRR
$330M
$131M 1.76%
539,962
+8,400
+2% +$1.74M
ASML icon
16
ASML
ASML
$634B
$119M 1.6%
172,000
– –
TT icon
17
Trane Technologies
TT
$97.3B
$117M 1.57%
633,500
+12,700
+2% +$2.26M
POOL icon
18
Pool Corp
POOL
$6.95B
$115M 1.55%
251,800
+1,600
+0.6% +$674K
ODFL icon
19
Old Dominion Freight Line
ODFL
$44.2B
$112M 1.51%
884,400
+126,230
+17% +$16.2M
ZYME icon
20
Zymeworks
ZYME
$1.67B
$111M 1.49%
3,200,728
+1,802,774
+129% +$57.2M
CTAS icon
21
Cintas
CTAS
$82.7B
$111M 1.49%
1,158,400
+181,600
+19% +$16.1M
W icon
22
Wayfair
W
$11.9B
$105M 1.41%
333,562
+87,130
+35% +$27.3M
XIFR
23
XPLR Infrastructure LP
XIFR
$1.12B
$101M 1.36%
1,327,100
-22,000
-2% -$1.57M
GTM
24
ZoomInfo Technologies
GTM
$978M
$101M 1.36%
1,942,351
-5,000
-0.3% -$235K
ARGX icon
25
argenx
ARGX
$54.6B
$100M 1.35%
333,000
+119,000
+56% +$33.8M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Eventide Asset Management held 169 positions worth $7.44B, up 10% from $6.75B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $295M of net new capital in Q2 2021, opening 15 new positions and adding to 63 existing holdings. Its largest new stake was nCino: 662,500 shares worth $39.7M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 40% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Verisk Analytics, an estimated $37.6M trimmed.

  • Eventide Asset Management's largest Q2 2021 buy was nCino: 662,500 shares worth $39.7M.
  • Eventide Asset Management added most to Zymeworks in Q2 2021, an estimated $57.2M increase.
  • Eventide Asset Management's biggest Q2 2021 reduction was Verisk Analytics, cutting an estimated $37.6M.
  • Eventide Asset Management fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $52M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $7.44B portfolio in Q2 2021.
  • Eventide Asset Management opened 15 new positions and closed 17 in Q2 2021.
  • Eventide Asset Management's portfolio value rose 10% quarter-over-quarter to $7.44B.

Based on Eventide Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.